Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Tigilanol tiglate by QBiotics Group for Soft Tissue Sarcoma: Likelihood of Approval
Tigilanol tiglate is under clinical development by QBiotics Group and currently in Phase II for Soft Tissue Sarcoma. According to...